Shuttle Pharma

Shuttle Pharma Hits Patient Enrollment Milestone for Phase 2 Ropidoxuridine Clinical Trial

January 21, 2025

Wrecking ball shaped like pills smashes into disease cell.

Shuttle Pharmaceuticals (NASDAQ: SHPH), a discovery and development-stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated…